Document is current
Any future updates will be listed below
-
Authors
Margolis, Gilad
Elbaz-Greener, Gabby
Ruskin, Jeremy N.
Roguin, Ariel
Amir, Offer
Rozen, Guy
- License Information
-
More Information
Article History
Accepted: 13 January 2022
First Online: 1 March 2022
Compliance with Ethical Standards
:
: Jeremy N. Ruskin reports participation on a Data Safety Monitoring Board or Advisory Board for Acesion Pharma, InCarda, and Janssen. In addition, he reports stock or stock options in Ablacor, Element Science, Infobionic, LuxCath, NewPace, and Celero Systems. The other authors declare that they have no conflict of interest.
: This article does not contain any studies with human or animal subjects performed by any of the authors.
